David Engelhardt
David Engelhardt has been employed in equity research at TraderFox GmbH since April 2022. David completed his Bachelor's degree in Economics at Friedrich-Alexander-University in Erlangen-Nuremberg in 2018 and subsequently obtained a Master's degree in Business Administration at the University of Bamberg. Since 2019, he has been independently engaged with the topics of stock markets, equities, and capital markets. For the equity magazine, he is mainly responsible for the Hot News section and regularly publishes his own articles there. Since March 2023, he has been reporting as the editor-in-chief for the Traderfox equity magazine Small Caps Investor about small companies with enormous growth potential.
Latest from David Engelhardt
Lattice Semiconductor: The Champion of Efficient Intelligence
Allison Transmission: Between Highly Profitable Market Dominance and the Leap Into the Electric Future
As a global leader in fully automatic commercial vehicle transmissions, Allison benefits from high...
Marvell Technology on Record Track: The Comeback of the Network Specialists
The stock of Marvell Technology (NASDAQ: MRVL) is currently experiencing an impressive renaissance...
Aehr Test Systems: AI Turbo instead of E-Car Brake
The semiconductor market is undergoing a transformation, and while the masses are still chasing the big...
Plexus Corp.: The Discreet Architect Behind the High-Tech Giants
Plexus successfully distinguishes itself from the low-margin EMS mass market by focusing on highly...
Rheinmetall and Destinus: a new Heavyweight for Europe's Rocket Defense
Rheinmetall and the aerospace company Destinus are joining forces to massively ramp up rocket production...
Anterix: why the Company is the Most Lucrative bet on the Power Grids of the Future
Anterix operates like a digital real estate owner, leasing its valuable nationwide monopoly on 900...
Eli Lilly: Foundayo is Cementing Market Leadership in the Obesity Sector
The market for obesity treatments is currently experiencing a fundamental shift, and Eli Lilly is positioning...
Porsche Deliveries Decline in the First Months of 2026
Deliveries in Porsche's largest sales region North America fell by 11%, in China by 21%. Decline in...
The Shovel Seller of Tech Giants: Why Keysight Technologies is Indispensable
In the gold rush atmosphere surrounding AI, 6G, and e-mobility, investors often focus on the large end-product...
Viasat: Profitable Niches in the Shadow of Ruthless Starlink Competition
Viasat has a robust, vertically integrated business model that generates reliable revenue, particularly...
Pasqal Goes Public: A New Opportunity for Quantum Optimists
Investors in the quantum sector have experienced turbulent months. This period has been marked by a series...
Here's why the Levi Strauss Stock Could be a Tailored Investment Now
When we think of Levi Strauss, we often just picture the classic 501 jeans. However, a look at the latest...
Tsakos Energy: From Pure oil Tanker Business to Energy Transition Pioneer
Tsakos Energy combines financial stability with the opportunity for massive profit increases during...
Ackman's Pershing Square Offers Over $63 Billion for Universal Music Group
The deal involves a merger of Universal with c. Bill Ackman's Pershing Square Capital announced...
TD SYNNEX: The Heart of the IT Supply Chain: More than Just Logistics
As one of the largest IT distributors in the world, the company serves as an indispensable link between...
The Approval of Eli Lilly’s Obesity Pill Opens a new Front in the Weight-Loss war
Eli Lilly's pill will compete in the booming, billion-dollar market for obesity medications against a...
The Digital Renaissance of the Gourmet Burger: Why Shake Shack is now Convincing
For a long time, Shake Shack was associated with the image of an excellent but somewhat sluggish "fine...
Seaboard Corporation: A Silent Giant Between Agriculture and Deep-sea Shipping
Seaboard is a crisis-resistant, vertically integrated agribusiness conglomerate that achieves above-average...
United Therapeutics: From Niche Player to Giant in Organ Technology
With the excellent study data from March 30, 2026, United Therapeutics is on the brink of tapping into...
Microsoft Invests Over $1 Billion in Thailand for Cloud and AI Infrastructure
The tech giant also plans massive investments in cybersecurity and digital sovereignty. Microsoft...